Therapeutic and diagnostic devices maker AngioDynamics (ANGO) has won the green signal of the U.S. Food and Drug Administration (“FDA”) for its NeverTouch Direct procedure kit. The new kit has been ...
SAN FRANCISCO (MarketWatch) -- AngioDynamics Inc. said late Friday that it intends to defend its position in a patent infringement suit filed against it by VNUS Medical Technologies Inc. .
AngioDynamics, a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is to acquire all the outstanding capital stock of Vortex ...
The U.S. District Court has denied an attempt by a Boston area company to have AngioDynamics Inc. declared in contempt of court for selling its NeverTouch product line. Diomed Inc. of Andover, Mass.
AngioDynamics Inc. is headed to trial on a two-year-old patent infringement case it says could cost it up to $36 million. VNUS Medical Technologies (Nasdaq: VNUS) of San Jose, Calif., had filed suit ...
July 3 (Reuters) - AngioDynamics Inc. said it continues to dispute a patent verdict that prohibited it and Vascular Solutions Inc. from selling some products that infringed on a Diomed Holdings Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results